Home -> Law Blog Directory -> International Law Blogs -> Trade Regulation Talk

International Law

: Trade Regulation Talk

$140 Million Jury Verdict in Favor of Kaiser in Neurontin Off-Label Marketing Case Upheld

This posting was written by Jody Coultas, Contributor to Wolters Kluwer Antitrust Law Daily. The U.S. Court of Appeals in Boston affirmed verdicts of over $140 million, reached by both a jury and trial court, in favor of Kaiser Foundation Health Plan, Inc. for injuries suffered as a result of Pfizer, Inc.?s fraudulent scheme to market its epilepsy drug Neurontin for off-label uses (Kaiser Foundation Health Plan, Inc. v. Pfizer, Inc., April 3, 2013, Lynch, S.).Neurontin was approved by the FDA as read more

Full post as published by Trade Regulation Talk on April 09, 2013 (boomark / email).